GLP-1 RAs and Dietary Intake and Body Composition
Longitudinal Effects of GLP-1 Receptor Agonists on Dietary Intake and Body Composition
To assess longitudinal changes in dietary intake, body composition and metabolism with GLP-1 RA use.
研究概览
研究类型
注册 (估计的)
联系人和位置
学习地点
-
-
Ohio
-
Athens、Ohio、美国、45701
- 招聘中
- Exercise Physiology Lab
-
接触:
- Angela Hillman, PhD
- 电话号码:740-593-0153
- 邮箱:hillman@ohio.edu
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
取样方法
研究人群
People taking GLP-1 RA medications
描述
Inclusion Criteria:
- Currently taking GLP-1 medications and have been taking them for less than a month
- between the ages of 18-75 years
Exclusion Criteria:
- Not between the ages of 18-75 years
- Not currently using GLP-1 medications
- Have been using GLP-1 medications for 1 month or longer
- Currently pregnant
- Currently nursing
- Bariatric surgery in the last 3 months
- Have an implanted cardiac device, such as a pacemaker or defibrillator
- Not willing to have a DEXA (full body x-ray) at the start and end of the 12 week study period
- Not willing to have a bioelectrical impedance body composition scan at the start and every 2 weeks during the 12 week study period
- Not willing to have your resting metabolism measured at the start and end of the 12 week study period
- Not willing to track your diet at the beginning and end of the study
- Not willing to complete surveys assessing depression, food noise and disordered eating
学习计划
研究是如何设计的?
设计细节
- 观测模型:COHORT
- 时间观点:PROSPECTIVE
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
change in body mass
大体时间:12 weeks
|
change in body weight measured in kg using BIA and DEXA |
12 weeks
|
|
change in skeletal muscle mass
大体时间:12 weeks
|
change in skeletal muscle mass measured in kg using BIA and DEXA |
12 weeks
|
|
change in body fat mass
大体时间:12 weeks
|
change in body fat mass measured in kg using BIA and DEXA |
12 weeks
|
|
change in resting metabolism
大体时间:12 weeks
|
change in resting metabolic rate in kcals/day as measured via indirect calorimetry |
12 weeks
|
|
change in substrate utilization rates
大体时间:12 weeks
|
change in resting carbohydrate and fat oxidation rates as measured via indirect calorimetry |
12 weeks
|
|
change in bone mineral content
大体时间:12 weeks
|
change in bone mineral content measured via DEXA and BIA |
12 weeks
|
|
change in bone mineral density
大体时间:12 weeks
|
change in bone mineral density measured via DEXA |
12 weeks
|
|
change in total daily caloric intake
大体时间:12 weeks
|
change in total daily caloric intake measured via 24 hour food diary |
12 weeks
|
|
change in daily carbohydrate intake
大体时间:12 weeks
|
change in daily carbohydrate intake measured via 24 hour food diary |
12 weeks
|
|
change in daily fat intake
大体时间:12 weeks
|
change in daily fat intake measured via 24 hour food diary |
12 weeks
|
|
change in daily protein intake
大体时间:12 weeks
|
change in daily protein intake measured via 24 hour food diary |
12 weeks
|
|
change in daily mineral intake
大体时间:12 weeks
|
change in daily mineral intake measured via 24 hour food diary |
12 weeks
|
|
change in daily vitamin intake
大体时间:12 weeks
|
change in daily vitamin intake measured via 24 hour food diary |
12 weeks
|
合作者和调查者
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他研究编号
- IRB-FY26-568
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.